
AI pluses, minuses in business sectors focus of CSUCI forum
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Latigo Bio shares positive news, appoints chief medical officer
Thousand Oaks-based Latigo Biotherapeutics, a company with the mission of creating non-opioid pain medication, shared positive phase 1 results for its lead candidate. In its phase 1 clinical trial, data from LTG-001 showed that the oral treatment aimed to treat acute and chronic pain at its source was “well tolerated with rapid absorption.” The trial Read More →

Ventura fiber optics firm sells operations

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Amgen doubles down on India biotech

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Inogen stock pops after earnings beat
By Julia Staley Special to the Business Times Inogen, the Goleta-based developer of portable oxygen concentrators, saw its shares increase by 44.67% after its second-quarter earnings announcement on Aug. 6. The day after the earnings announcement, shares were valued at $11.08. Share value has continued to increase with shares valued at $12.49 on Aug. 13. Read More →